Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Italy PM says vaccine supply delays are serious contract violations

01/23/2021 | 11:38am EST

MILAN, Jan 23 (Reuters) - Delays in supply of vaccines to Italy from Pfizer and, possibly, AstraZeneca amount to serious violations of contractual agreements and Rome will take countermeasures, Prime Minister Giuseppe Conte said.

In a post on Facebook Conte said the delays were causing "enormous damage" to Italy and other countries.

"This is unacceptable," Conte wrote. (Reporting by Valentina Za; Editing by Alex Richardson)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 2.14% 7005 Delayed Quote.-6.36%
FACEBOOK INC -3.39% 255.31 Delayed Quote.-3.25%
PFIZER INC. -0.12% 34.35 Delayed Quote.-6.57%
All news about ASTRAZENECA PLC
04:06pASTRAZENECA  : The latest news on COVID-19 developments in Canada for March 8
AQ
12:29pTHE LATEST : More than 100,000 have died of COVID-19 in Italy
AQ
11:20aWHO says influenza-like illness post COVID-19 vaccinations expected side effe..
RE
10:46aASTRAZENECA  : Berenberg reiterates its Buy rating
MD
10:21aASTRAZENECA  : Germany looks to AstraZeneca shot to boost vaccine rollout
AQ
07:30aASTRAZENECA  : Italy Green-lights AstraZeneca's COVID-19 Vaccine For People Over..
MT
06:35aASTRAZENECA  : Barclays Lifts AstraZeneca PT, Keeps Overweight Rating
MT
06:11aASTRAZENECA  : Indonesia's Bio Farma To Receive 1.1 Million AstraZeneca COVID-19..
MT
05:38aASTRAZENECA  : Barclays gives a Buy rating
MD
05:38aTHE LATEST : Germany ramps up use of AstraZeneca vaccine
AQ
More news
Financials (USD)
Sales 2021 30 875 M - -
Net income 2021 4 710 M - -
Net Debt 2021 11 049 M - -
P/E ratio 2021 19,4x
Yield 2021 4,07%
Capitalization 90 026 M 124 B -
EV / Sales 2021 3,27x
EV / Sales 2022 2,86x
Nbr of Employees 76 100
Free-Float 95,8%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 129,45 $
Last Close Price 70,05 $
Spread / Highest target 124%
Spread / Average Target 84,8%
Spread / Lowest Target 35,4%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC-6.36%124 268
JOHNSON & JOHNSON-0.81%410 337
ROCHE HOLDING AG-3.56%274 753
PFIZER INC.-6.57%191 873
ABBVIE INC.-0.42%188 420
ELI LILLY AND COMPANY22.55%187 971